Immunocore Holdings (IMCR) Depreciation and Depletion (2023 - 2026)

Immunocore Holdings' (IMCR) quarterly Depreciation and Depletion came in at $948000.0 in Q1 2026, up 11.01% year-on-year from $854000.0 in Q1 2025, and up 13.67% quarter-over-quarter from $834000.0 in Q4 2025.

Immunocore Holdings (IMCR) Depreciation and Depletion (2023 - 2026) Analysis & Trends

Immunocore Holdings has disclosed Depreciation and Depletion across 4 years of filings, most recently posting $948000.0 for Q1 2026.

  • Depreciation and Depletion for Q1 2026 came in at $948000.0, up 11.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.4 million (down 16.98% YoY), and the FY2025 annual result was $3.3 million, down 22.31% from the prior year.
  • Depreciation and Depletion came in at $948000.0 for Q1 2026 at Immunocore Holdings, up from $834000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $1.2 million in Q4 2024 to a low of $780000.0 in Q2 2025.
  • The 4-year median for Depreciation and Depletion is $992000.0 (2024), against an average of $962153.8.
  • Across the five-year window, Depreciation and Depletion rose 12.98% in 2024 and slipped 28.47% in 2025, its largest moves.
  • Immunocore Holdings' Depreciation and Depletion stood at $1.0 million in 2023, then grew by 12.98% to $1.2 million in 2024, then slipped by 28.47% to $834000.0 in 2025, then increased by 13.67% to $948000.0 in 2026.
  • The last three Depreciation and Depletion figures came in at $948000.0 (Q1 2026), $834000.0 (Q4 2025), and $798000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - 1,395.22
2 Belite Bio 55,234.00 Bn 55,234.00 Bn - -
3 Quantum Biopharma 17,823.14 Bn 17,823.14 Bn - -
4 Legend Biotech 3,624.50 Bn 3,624.21 Bn 242.10 Mn -
5 Akari Therapeutics 1,745.73 Bn 1,745.73 Bn - -
6 Evaxion A 1,540.85 Bn 1,540.84 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -1,330.00
8 Vertex Pharmaceuticals 112.57 Bn 105.33 Bn 2.59 Bn -
9 Abivax 93.46 Bn 93.46 Bn - -
10 Immunocore Holdings 1.46 Bn 616.35 Mn 106.24 Mn 948,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 948,000.00
Mar 31, 2026 948,000.00
Dec 31, 2025 834,000.00
Dec 31, 2025 834,000.00
Sep 30, 2025 798,000.00
Sep 30, 2025 798,000.00
Jun 30, 2025 780,000.00
Jun 30, 2025 780,000.00
Mar 31, 2025 854,000.00
Mar 31, 2025 854,000.00
Dec 31, 2024 1.17 Mn
Dec 31, 2024 1.17 Mn
Sep 30, 2024 1.04 Mn
Sep 30, 2024 1.04 Mn
Jun 30, 2024 992,000.00
Jun 30, 2024 992,000.00
Mar 31, 2024 1.01 Mn
Mar 31, 2024 1.01 Mn
Dec 31, 2023 1.03 Mn
Dec 31, 2023 1.03 Mn